Seeking Alpha

Novartis AG (NVS)

()

News & PR
Market Currents

Buzz
Twitter: NVS

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Many Reasons to Launch a Global Generic Drug ETF

Dec 24 • Mike Havrilla • 4 Comments
Pharma Spreads Holiday Cheer in Bevy of Biotech Deals

Dec 24 • The Burrill Report • Comment!
Sanofi Pulls the Plug on Two Drugs: Biotech's Latest Mishaps

Dec 24 • The Burrill Report • Comment!
Sanofi-Aventis Going OTC with Chattem Buy

Dec 21 • EP Vantage • 2 Comments
China Biotech Week in Review: Medical Device, Big Pharma Milestones

Dec 20 • ChinaBio Today • 2 Comments
Novartis Increases China Commitment: Opens Suzhou Plant, Technical R&D Center

Dec 16 • ChinaBio Today • Comment!
Glaxo-Intercell Deal Could Bring New Developments to Vaccine Market

Dec 11 • EP Vantage • Comment!
Astra-Zeneca Flies to 'Jupiter' on Drug Results

Dec 6 • Larry Meyers • 6 Comments
Novartis Could Be the Biggest Loser in Alcon Deal with Nestle

Dec 6 • Stephen Rosenman • 4 Comments
H1N1: What It Means for Pharma

Dec 2 • R. Scott Raynovich • 2 Comments
Merck KGaA: Another Stumble Leaves Investors Worried

Dec 1 • EP Vantage • 1 Comment
Incyte's Collaboration with Novartis AG Presents Great Opportunity

Dec 1 • Zacks.com • Comment!
8 HealthCare Stocks with 3%+ Dividends

Nov 29 • Hao Jin • 9 Comments
Novartis Partners with U.S. Government for Faster Flu Vaccine Manufacturing

Nov 26 • The Burrill Report • Comment!
Novartis Deal Gives Incyte a Boost

Nov 25 • EP Vantage • Comment!
When CDS Spreads and Equity Prices Rise in Tandem

Nov 24 • Jim Delaney • 1 Comment
Wall Street Breakfast: Must-Know News

Nov 23 • Suzanne Miller • 15 Comments
Titan Pharmaceuticals: Finally Reaching Its Potential

Nov 17 • VFC's Stock House • 1 Comment
Novartis Says Weak IP Protection Makes India R&D Impossible

Nov 13 • ChinaBio Today • Comment!
The Complete List of Swiss ADR Stocks

Nov 9 • David Hunkar • 3 Comments
D.C. Vaccine Conference: Why Investors Should Stay Tuned

Nov 9 • M. E. Garza • Comment!
China Is Growth Market for Novartis

Nov 8 • The Burrill Report • Comment!
Week in Review: Major Investments in China Biotech Companies

Nov 8 • ChinaBio Today • 1 Comment
EFA: Diversify Your Portfolio Outside the U.S.

Nov 8 • Hao Jin • 4 Comments
Novartis Joins Global Interest in Vaccines with Increased China Investments

Nov 5 • ChinaBio Today • Comment!
Novartis Seeks to Make China One of Its Top Three Global Markets

Nov 4 • ChinaBio Today • Comment!
Determining Potential in Health Care Stocks

Oct 30 • J. Royden Ward • 4 Comments
Healthcare Profits: Assessing Company Sensitivity to Obamacare

Oct 30 • Richard Shaw • 11 Comments
Stock Screener: 10 Foreign Stocks with Caps Above $100B, Yields Above 3%

Oct 29 • David Hunkar • Comment!
Alcon Delivers, Moves Ever Closer to $181

Oct 28 • Stephen Rosenman • 3 Comments
Venture Capital Flows to Biotech as Public Financing Takes a Breather

Oct 25 • The Burrill Report • Comment!
Biotech Companies Turn to Capital Markets

Oct 18 • The Burrill Report • Comment!
Dow 10k: The Higher They Rise, The Harder They Fall

Oct 15 • Matthew Rafat • 20 Comments
Vanda Needs to Make a Move

Oct 14 • VFC's Stock House • 1 Comment
Titan Pharmaceuticals: Patience Is Starting to Pay Off

Oct 13 • VFC's Stock House • 1 Comment
Vanda Headed Higher on Novartis Deal

Oct 13 • VFC's Stock House • Comment!
Novartis' Vanda Deal Is Great News- for Titan Pharma

Oct 13 • VFC's Stock House • 1 Comment
H1N1: How to Buy into the Fear

Oct 7 • Jim Van Meerten • 1 Comment
Good News for Novartis

Sep 30 • Zacks.com • Comment!
Emisphere: The Most Undervalued Biotech

Sep 30 • Joseph Ramelli • 4 Comments
Waiting for New Novartis HBP Drug

Sep 28 • Zacks.com • Comment!

Novartis AG (NVS)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers